Position in NUVB
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,755,129
+$2,662,641 QoQ
Shares Held
485,058
+2149.9% QoQ
Ownership
0.138%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#51
of 242 holders
Holding Since
Jun 2021
6 quarters on record
Voting authority
Sole 91%
Shared 0%
None 9%
Common Shares in NUVB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Trexquant Investment LP holds $612,941,942 across 144 Biotechnology names. NUVB ranks #64 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
505,160 | $35,376,354 | |
| 2 | TWST |
Twist Bioscience Corp
|
255,271 | $26,262,280 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
41,839 | $26,088,290 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
120,122 | $22,496,448 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
83,679 | $20,482,108 | |
| 6 | RARE |
Ultragenyx Pharmaceutical Inc.
|
556,385 | $18,577,695 | |
| 7 | INSM |
INSMED Inc
|
156,553 | $16,691,680 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
275,712 | $15,164,160 |
All Filings in NUVB
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,755,129 | 485,058 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $92,488 | 21,559 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,674,507 | 186,887 | Shares | Sole | 2026-02-17 | |
| 2022-03-31 | $231,608 | 44,032 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $208,046 | 24,476 | Shares | Sole | 2022-02-14 | |
| 2021-06-30 | $212,947 | 22,873 | Shares | Sole | 2021-08-12 | |
| No filing history on record for this holder in this stock. | ||||||